GETTING STARTED
with ZEPOSIA
If you and your MS healthcare team decide to move forward with ZEPOSIA, we’ll help you get started in a way that works for you. And a dedicated MS Nurse Navigator will be with you every step of the way.
INDICATION
ZEPOSIA® (ozanimod) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
It is not known if ZEPOSIA is safe and effective in children.
If you and your MS healthcare team decide to move forward with ZEPOSIA, we’ll help you get started in a way that works for you. And a dedicated MS Nurse Navigator will be with you every step of the way.
If you and your healthcare team decide to move forward with ZEPOSIA, you'll work together to submit a Start Form (which is a prescription that contains additional information specific to ZEPOSIA).
To avoid unnecessary exposure to others during the current health crisis, consider asking your MS healthcare team if they offer telehealth appointments.
Once your Start Form is received, you'll get a call from your MS Nurse Navigator who will:
Before taking ZEPOSIA, a few routine tests will help determine if it's the right treatment for you.
Your MS Nurse Navigator or healthcare team will help you schedule them, and the first two may be completed with an in-home visit*:
An electrocardiogram (ECG)—a common test that
can be completed with an at-home appointment. It uses small sensors to monitor your heart and makes sure it's working normally before you start treatment.
Bloodwork—including complete blood count and liver function test that can be completed with an at-home appointment.
An eye exam—this isn't required for everyone—only for people with a history of macular edema or uveitis.
Your health is a priority, and during the COVID-19 pandemic, you may want to limit in-person contact. With ZEPOSIA, some people may be able to start treatment without even leaving their home.
There may be costs associated with some of the routine medical tests, but depending on where these tests take place eligible patients may qualify for reimbursement or incur no costs at all.† You can learn more about costs based on your insurance here.
Once you’ve been approved to begin treatment, a representative from a
specialty pharmacy will contact you to arrange shipping of your ZEPOSIA Starter Kit.
The ZEPOSIA Starter Kit includes medication for the first 37 days of treatment and has two parts:
A 7-day Starter Pack, which increases your dosage gradually. Each capsule is labeled by day and color-coded by dosage size. You'll take one capsule each day.
A 30-day supply, which you'll begin taking on day 8 (after completing the 7-day Starter Pack). These orange capsules are the regular daily dosage (0.92 mg) of ZEPOSIA.
Your specialty pharmacy will continue to deliver ZEPOSIA to your home or office every month. It’s worth noting:
Eligible patients can receive a co-pay savings offer to help with the monthly cost of treatment.
‡Program terms and eligibility criteria apply.
*Home visits for routine medical tests are not available to people living in Massachusetts, Minnesota, and Rhode Island.
†Depending on insurance coverage, eligible patients may receive a medical assessment benefit offer for out-of-pocket costs for the initial blood tests and ECG screening, where the full cost is not covered by patients’ insurance. Maximum savings limit applies; patient out-of-pocket expenses may vary. This program is not health insurance. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Please click here for Program Terms, Conditions, and Eligibility Criteria.
Do not take ZEPOSIA if you:
Talk to your healthcare provider before taking ZEPOSIA if you have any of these conditions or do not know if you have any of these conditions.
ZEPOSIA may cause serious side effects, including:
Call your healthcare provider right away if you have any of these symptoms of an infection during treatment with ZEPOSIA and for 3 months after your last dose of ZEPOSIA:
Your healthcare provider may delay starting or may stop your ZEPOSIA treatment if you have an infection.
Call your healthcare provider if you experience the following symptoms of slow heart rate:
Follow directions from your healthcare provider when starting ZEPOSIA and when you miss a dose.
Continue reading for additional possible serious side effects of ZEPOSIA.
Before taking ZEPOSIA, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take or have recently taken, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using ZEPOSIA with other medicines can cause serious side effects. Especially tell your healthcare provider if you take or have taken:
You should not receive live vaccines during treatment with ZEPOSIA, for at least 1 month before taking ZEPOSIA and for 3 months after you stop taking ZEPOSIA. Vaccines may not work as well when given during treatment with ZEPOSIA.
ZEPOSIA can cause serious side effects, including:
The most common side effects of ZEPOSIA can include:
These are not all of the possible side effects of ZEPOSIA. For more information, ask your healthcare provider or pharmacist.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
ZEPOSIA® (ozanimod) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
It is not known if ZEPOSIA is safe and effective in children.
Please see full Prescribing Information, including Medication Guide.
ZEPOSIA® (OZANIMOD) CO-PAY PROGRAM
TERMS AND CONDITIONS